STN1
Basic information
Region (hg38): 10:103856806-103918332
Previous symbols: [ "OBFC1" ]
Links
Phenotypes
GenCC
Source:
- Coats plus syndrome (Supportive), mode of inheritance: AR
- cerebroretinal microangiopathy with calcifications and cysts 2 (Moderate), mode of inheritance: AR
- cerebroretinal microangiopathy with calcifications and cysts 2 (Strong), mode of inheritance: AR
- cerebroretinal microangiopathy with calcifications and cysts 2 (Moderate), mode of inheritance: AR
- cerebroretinal microangiopathy with calcifications and cysts 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cerebroretinal microangiopathy with calcifications and cysts 2 | AR | Cardiovascular; Gastrointestinal; Hematologic | Among other features, individuals have been described with gastrointestinal bleeding, and awareness may allow medical management (eg, with thalidomide treatment and argon plasma coagulation) as well as prompt treatment of urgent situations; RBC transfusions have been described as necessary due to bone marrow failure | Cardiovascular; Gastrointestinal; Hematologic; Neurologic; Ophthalmologic | 27432940 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 48 | ||||
missense | 96 | 103 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 7 | 11 | 18 | |||
non coding | 36 | 40 | ||||
Total | 0 | 0 | 115 | 86 | 6 |
Variants in STN1
This is a list of pathogenic ClinVar variants found in the STN1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-103882684-T-C | Uncertain significance (Nov 01, 2022) | |||
10-103882685-C-T | Uncertain significance (Nov 25, 2022) | |||
10-103882690-C-T | Likely benign (Jan 21, 2023) | |||
10-103882691-G-A | Cerebroretinal microangiopathy with calcifications and cysts 2 • Inborn genetic diseases | Uncertain significance (Dec 01, 2022) | ||
10-103882695-T-C | Uncertain significance (Feb 23, 2022) | |||
10-103882710-T-C | Uncertain significance (Aug 21, 2022) | |||
10-103882729-C-T | Likely benign (Jun 27, 2022) | |||
10-103882735-C-T | Likely benign (Jan 21, 2022) | |||
10-103882736-T-C | Uncertain significance (Jul 12, 2022) | |||
10-103882740-G-A | Likely benign (Jul 24, 2022) | |||
10-103882766-G-A | Uncertain significance (Jul 30, 2022) | |||
10-103882770-C-T | Uncertain significance (Aug 12, 2022) | |||
10-103882771-G-A | Benign (Jan 11, 2024) | |||
10-103882776-G-A | Likely benign (Jan 07, 2022) | |||
10-103882780-C-T | Likely benign (Jan 28, 2023) | |||
10-103882781-G-A | Uncertain significance (Aug 22, 2022) | |||
10-103882781-G-C | Uncertain significance (Nov 01, 2022) | |||
10-103882784-C-T | Likely benign (Jan 13, 2024) | |||
10-103882785-G-A | Uncertain significance (Oct 03, 2023) | |||
10-103882786-G-A | Likely benign (Jul 18, 2023) | |||
10-103882797-G-A | Inborn genetic diseases | Uncertain significance (Oct 06, 2023) | ||
10-103882800-C-A | Uncertain significance (Aug 10, 2022) | |||
10-103882804-G-A | Likely benign (Oct 15, 2021) | |||
10-103882804-G-C | Likely benign (Feb 10, 2022) | |||
10-103882811-A-G | Uncertain significance (Jun 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STN1 | protein_coding | protein_coding | ENST00000224950 | 9 | 35664 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.30e-10 | 0.254 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.388 | 186 | 201 | 0.923 | 0.0000104 | 2436 |
Missense in Polyphen | 39 | 56.526 | 0.68995 | 751 | ||
Synonymous | -0.0288 | 75 | 74.7 | 1.00 | 0.00000388 | 673 |
Loss of Function | 0.778 | 17 | 20.8 | 0.816 | 0.00000115 | 236 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000333 | 0.000333 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000247 | 0.000246 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000361 | 0.000359 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the CST complex proposed to act as a specialized replication factor promoting DNA replication under conditions of replication stress or natural replication barriers such as the telomere duplex. The CST complex binds single-stranded DNA with high affinity in a sequence-independent manner, while isolated subunits bind DNA with low affinity by themselves. Initially the CST complex has been proposed to protect telomeres from DNA degradation (PubMed:19854130). However, the CST complex has been shown to be involved in several aspects of telomere replication. The CST complex inhibits telomerase and is involved in telomere length homeostasis; it is proposed to bind to newly telomerase-synthesized 3' overhangs and to terminate telomerase action implicating the association with the ACD:POT1 complex thus interfering with its telomerase stimulation activity. The CST complex is also proposed to be involved in fill-in synthesis of the telomeric C-strand probably implicating recruitment and activation of DNA polymerase alpha (PubMed:22964711, PubMed:22763445). The CST complex facilitates recovery from many forms of exogenous DNA damage; seems to be involved in the re- initiation of DNA replication at repaired forks and/or dormant origins (PubMed:25483097). Required for efficicient replication of the duplex region of the telomere. Promotes efficient replication of lagging-strand telomeres (PubMed:22863775, PubMed:22964711). Promotes general replication start following replication-fork stalling implicating new origin firing (PubMed:22863775). May be in involved in C-strand fill-in during late S/G2 phase independent of its role in telomere duplex replication (PubMed:23142664). {ECO:0000269|PubMed:19648609, ECO:0000269|PubMed:19854130, ECO:0000269|PubMed:22763445, ECO:0000269|PubMed:22863775, ECO:0000269|PubMed:22964711, ECO:0000269|PubMed:23142664, ECO:0000269|PubMed:25483097, ECO:0000305|PubMed:23851344}.;
- Disease
- DISEASE: Cerebroretinal microangiopathy with calcifications and cysts 2 (CRMCC2) [MIM:617341]: An autosomal recessive, multisystemic disorder characterized by intrauterine growth retardation and, later in life, premature aging symptoms, including poor growth, graying hair, liver fibrosis, portal hypertension, esophageal varices, osteopenia, pancytopenia, hypocellular bone marrow, and vascular telangiectasia resulting in gastrointestinal bleeding. Brain calcifications and white matter changes are responsible for signs including spasticity, ataxia, or dystonia observed in some patients. {ECO:0000269|PubMed:27432940}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lung fibrosis
(Consensus)
Recessive Scores
- pRec
- 0.0917
Intolerance Scores
- loftool
- rvis_EVS
- 0.35
- rvis_percentile_EVS
- 74.37
Haploinsufficiency Scores
- pHI
- 0.0608
- hipred
- N
- hipred_score
- 0.409
- ghis
- 0.383
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Stn1
- Phenotype
Zebrafish Information Network
- Gene name
- stn1
- Affected structure
- pro-T cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- telomere maintenance;telomere maintenance via telomere lengthening;telomere capping;negative regulation of telomere maintenance via telomerase;positive regulation of DNA replication
- Cellular component
- nuclear chromosome, telomeric region;fibrillar center;nucleus;nucleoplasm;intracellular membrane-bounded organelle;intermediate filament cytoskeleton;CST complex
- Molecular function
- single-stranded DNA binding;protein binding;telomeric DNA binding;single-stranded telomeric DNA binding